Biohaven Ltd. - Common Stock (BHVN)

Historical Holders from Q2 2022 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
BHVN on NYSE
Shares outstanding
105,814,266
Price per share
$11.29
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
84,312,948
Holdings value
$1,263,794,324
% of all portfolios
0%
Share change
-2,874,520
Value change
-$38,283,731
Average buys %
+0%
Average sells %
-0%
Number of holders
259
Price from insider filings
$9.93
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Biohaven Ltd. - Common Stock (BHVN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 6.4% +30% $101,649,416 +$25,795,961 6,772,113 +34% JANUS HENDERSON GROUP PLC 30 Sep 2025
VANGUARD GROUP INC 2.7% $43,156,602 2,875,190 The Vanguard Group 30 Sep 2025
As of 30 Sep 2025, Biohaven Ltd. - Common Stock (BHVN) has 259 institutional shareholders filing 13F forms. They hold 84,312,948 shares of 105,814,266 outstanding shares (80%) .

Top 25 institutional shareholders own 57% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 7.4% 7,874,891 +4.5% 0% $118,202,120
JANUS HENDERSON GROUP PLC 6.4% 6,772,113 +34% 0.05% $101,680,216
STIFEL FINANCIAL CORP 6.2% 6,611,350 +0.06% 0.09% $99,236,347
SUVRETTA CAPITAL MANAGEMENT, LLC 5.3% 5,620,271 0% 2.6% $84,360,268
STATE STREET CORP 4% 4,258,283 +20% 0% $63,916,828
VANGUARD GROUP INC 2.7% 2,875,190 -69% 0% $43,156,603
Bellevue Group AG 2.6% 2,802,853 0% 0.87% $42,070,824
FMR LLC 2.3% 2,426,904 +46% 0% $36,427,829
GEODE CAPITAL MANAGEMENT, LLC 1.9% 2,060,208 +1.4% 0% $30,928,678
PRICE T ROWE ASSOCIATES INC /MD/ 1.9% 2,009,611 -37% 0% $30,165,000
INFINITUM ASSET MANAGEMENT, LLC 1.6% 1,700,000 +209% 4.7% $25,517,000
GOLDMAN SACHS GROUP INC 1.5% 1,578,390 +61% 0% $23,691,633
JPMORGAN CHASE & CO 1.3% 1,335,455 -48% 0% $20,045,179
D. E. Shaw & Co., Inc. 1.2% 1,266,792 +144% 0.02% $19,014,548
Qube Research & Technologies Ltd 1.2% 1,265,597 +834% 0.03% $18,996,611
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.2% 1,260,033 +100% 0.03% $18,913,095
UBS Group AG 1.1% 1,119,665 +111% 0% $16,806,171
ARS Investment Partners, LLC 1% 1,102,549 -7.2% 1.1% $16,549,260
STEMPOINT CAPITAL LP 0.96% 1,017,311 +482% 3.1% $15,269,838
Capital Research Global Investors 0.96% 1,011,530 +109% 0% $15,183,065
CITADEL ADVISORS LLC 0.94% 997,793 +209% 0.01% $14,976,873
MILLENNIUM MANAGEMENT LLC 0.91% 968,153 -41% 0.01% $14,531,977
BNP PARIBAS FINANCIAL MARKETS 0.8% 843,564 0% 0.01% $12,661,896
TWO SIGMA INVESTMENTS, LP 0.76% 799,600 +986% 0.02% $12,001,996
JANE STREET GROUP, LLC 0.76% 799,278 +201% 0.01% $11,997,164

Institutional Holders of Biohaven Ltd. - Common Stock (BHVN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 185,377 $2,027,444 +$1,261,930 $11.29 10
2025 Q3 84,312,948 $1,263,794,324 -$38,283,731 $15.01 259
2025 Q2 86,987,421 $1,227,652,713 -$143,894,967 $14.11 247
2025 Q1 88,106,650 $2,142,494,636 -$115,214,942 $24.04 260
2024 Q4 89,347,798 $3,336,972,938 +$197,478,899 $37.35 252
2024 Q3 85,402,160 $4,268,195,216 +$121,771,122 $49.97 252
2024 Q2 82,423,389 $2,860,927,742 +$234,484,892 $34.71 223
2024 Q1 73,474,392 $4,018,487,113 +$123,608,366 $54.69 243
2023 Q4 360,795 $15,455,418 +$13,241,079 $43.04 2
2023 Q3 61,435,992 $1,597,943,687 +$31,604,088 $26.01 182
2023 Q2 60,109,518 $1,437,826,409 -$122,598,294 $23.92 182
2023 Q1 66,532,303 $909,813,722 +$54,991,453 $13.66 170
2022 Q4 62,405,621 $867,719,978 +$450,274,813 $13.88 163
2022 Q3 3,300,822 $498,986,000 +$457,181,052 $151.17 27
2022 Q2 $23.92 1